{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T16:31:25Z","timestamp":1775233885294,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.bioorg.2019.01.060","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T18:59:16Z","timestamp":1549825156000},"page":"624-630","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Synthesis of sulfonamide, amide and amine hybrid pharmacophore, an entry of new class of carbonic anhydrase II inhibitors and evaluation of chemo-informatics and binding analysis"],"prefix":"10.1016","volume":"86","author":[{"given":"Attique","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pervaiz Ali","family":"Channar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aamer","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Kalesse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehar Ali","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fayaz Ali","family":"Larik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qamar","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mubashir","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain","family":"Raza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Yum","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2019.01.060_b0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1517\/13543776.12.2.217","article-title":"Applications of carbonic anhydrase inhibitors and activators in therapy","volume":"12","author":"Supuran","year":"2002","journal-title":"Exp. Opin. Ther. Patents"},{"key":"10.1016\/j.bioorg.2019.01.060_b0010","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1517\/13543776.10.5.575","article-title":"Carbonic anhydrase inhibitors and their therapeutic potential","volume":"10","author":"Supuran","year":"2000","journal-title":"Exp. Opin. Ther. Patents"},{"key":"10.1016\/j.bioorg.2019.01.060_b0015","series-title":"The Carbonic Anhydrases-New Horizons","first-page":"29","article-title":"Evolution and distribution of the carbonic anhydrase gene families","author":"Hewett-Emmett","year":"2000"},{"key":"10.1016\/j.bioorg.2019.01.060_b0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1097-0134(199702)27:2<272::AID-PROT12>3.0.CO;2-J","article-title":"Is cyanate a carbonic anhydrase substrate?","volume":"27","author":"Supuran","year":"1997","journal-title":"Proteins Struct. Funct. Genet."},{"key":"10.1016\/j.bioorg.2019.01.060_b0025","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrd2467","article-title":"Carbonic anhydrases: novel therapeutic applications for inhibitors and activators","volume":"7","author":"Supuran","year":"2008","journal-title":"Nat. Rev. Drug Discovery"},{"key":"10.1016\/j.bioorg.2019.01.060_b0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bioorg.2018.10.006","article-title":"Supuran, 3-Aminobenzenesulfonamides incorporating acyl thiourea moieties selectively inhibit the tumor-associated carbonic anhydrase isoform IX over the off-target isoforms I, II and IV","volume":"82","author":"Fattah","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.2174\/156802607780636690","article-title":"Carbonic anhydrases as drug targets \u2013 an overview","volume":"7","author":"Supuran","year":"2007","journal-title":"Curr. Top Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.bioorg.2018.01.031","article-title":"Synthesis, biological evaluation and computational studies of novel iminothiazolidinone benzenesulfonamides as potent carbonic anhydrase II and IX inhibitors","volume":"77","author":"Mahmood","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0045","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.bmc.2010.01.076","article-title":"Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine","volume":"18","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0050","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1016\/j.bmc.2014.10.041","article-title":"Inhibition studies of new ureidosubstituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV. Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine","volume":"22","author":"Ceruso","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0055","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bioorg.2019.01.060_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/14756366.2015.1122001","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"31","author":"Supuran","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"issue":"14","key":"10.1016\/j.bioorg.2019.01.060_b0065","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1042\/BCJ20160115","article-title":"Structure and function of carbonic anhydrases","volume":"473","author":"Supuran","year":"2016","journal-title":"Biochem. J."},{"key":"10.1016\/j.bioorg.2019.01.060_b0070","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.1016\/j.bmcl.2010.07.038","article-title":"Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV","volume":"20","author":"Innocenti","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2019.01.060_b0075","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1021\/jm011131t","article-title":"The sulfonamide group as an ideal anchor for the design of potent human carbonic anhydrase inhibitors: role of hydrogen-bonding networks in ligand binding and drug design","volume":"45","author":"Abbate","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0080","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ddr.21464","article-title":"Synthesis, carbonic anhydrase inhibitory activity and antioxidant activity of some 1,3-oxazine derivatives","volume":"79","author":"Qamar","year":"2018","journal-title":"Drug Develop. Res."},{"issue":"2","key":"10.1016\/j.bioorg.2019.01.060_b0085","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10025","article-title":"Carbonic anhydrase inhibitors","volume":"23","author":"Supuran","year":"2003","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2019.01.060_b0090","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/146164a0","article-title":"Sulphanilamide as a specific carbonic anhydrase inhibitor","volume":"146","author":"Mann","year":"1940","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bioorg.2019.01.060_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bmcl.2003.09.062","article-title":"Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX","volume":"14","author":"Abbate","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2019.01.060_b0100","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2174\/138161208783877947","article-title":"Diuretics: from classical carbonic anhydrase inhibitors to novel applications of the sulfonamides","volume":"14","author":"Supuran","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bioorg.2019.01.060_b0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/14756366.2016.1198900","article-title":"A class of sulfonamides as carbonic anhydrase I and II inhibitors","volume":"31","author":"Gokcen","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejmech.2014.03.023","article-title":"New aminobenzene sulfonamide-thiourea conjugates: synthesis and carbonic anhydrase inhibition and docking studies","volume":"78","author":"Zaib","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2019.01.060_b0115","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3109\/14756366.2013.866660","article-title":"Carbonic anhydrase inhibition by 1-aroyl-3-(4-aminosulfonylphenyl)thioureas","volume":"29","author":"Saeed","year":"2014","journal-title":"J. Enz. Inhib. Med. Chem."},{"issue":"07","key":"10.1016\/j.bioorg.2019.01.060_b0120","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1055\/s-0043-123998","article-title":"Synthesis and molecular docking studies of (E)-4-(substituted-benzylideneamino)-2H-Chromen-2-one derivatives: entry to new carbonic anhydrase class of inhibitors","volume":"68","author":"Fattah","year":"2018","journal-title":"Drug Res."},{"issue":"11","key":"10.1016\/j.bioorg.2019.01.060_b0125","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1016\/j.bmc.2011.04.040","article-title":"Discovery of new chromone containing sulfonamides as potent inhibitors of bovine cytosolic carbonic anhydrase","volume":"19","author":"Al-Rashida","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0130","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2017.09.059","article-title":"Design, synthesis, kinetic mechanism and molecular docking studies of novel 1-pentanoyl-3-arylthioureas as inhibitors of mushroom tyrosinase and free radical scavengers","volume":"141","author":"Larik","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2019.01.060_b0135","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera \u2013 a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2006","journal-title":"J. Comput. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2019.01.060_b0140","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi, psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2002","journal-title":"Proteins."},{"issue":"Pt1","key":"10.1016\/j.bioorg.2019.01.060_b0145","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.bioorg.2019.01.060_b0150","unstructured":"Studio, Discovery. \u201cversion 2.1.\u201d Accelrys, San Diego, CA, 2008."},{"key":"10.1016\/j.bioorg.2019.01.060_b0155","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1093\/nar\/gkg565","article-title":"VADAR: a web server for quantitative evaluation of protein structure quality","volume":"31","author":"Willard","year":"2003","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.bioorg.2019.01.060_b0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-2269-7_19","article-title":"Small-molecule library screening by docking with PyRx","volume":"1263","author":"Dallakyan","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2019.01.060_b0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/protein\/8.2.127","article-title":"LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions","volume":"8","author":"Wallace","year":"1996","journal-title":"Protein Eng."},{"key":"10.1016\/j.bioorg.2019.01.060_b0170","doi-asserted-by":"crossref","first-page":"609","DOI":"10.4103\/0250-474X.38464","article-title":"Recent trends in drug-likeness prediction: a comprehensive review of in silico methods","volume":"69","author":"Kadam","year":"2007","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.bioorg.2019.01.060_b0175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/cn200100h","article-title":"Knowledge-based, central nervous system (CNS) lead selection and lead optimization for CNS drug discovery","volume":"3","author":"Ghose","year":"2012","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2019.01.060_b0180","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1016\/j.ejmech.2010.07.069","article-title":"Molecular properties prediction, synthesis and antimicrobial activity of some newer oxadiazole derivatives","volume":"45","author":"Bakht","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2019.01.060_b0185","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2015.01.009","article-title":"The application of in silico drug-likeness predictions in pharmaceutical research","volume":"86","author":"Tian","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"4","key":"10.1016\/j.bioorg.2019.01.060_b0190","first-page":"142","article-title":"Concept of drug likeness in pharmaceutical research","volume":"6","author":"Jadhav","year":"2015","journal-title":"Int. J. Pharm. Bio Sci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818310782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818310782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T21:16:56Z","timestamp":1557868616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818310782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":38,"alternative-id":["S0045206818310782"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.01.060","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of sulfonamide, amide and amine hybrid pharmacophore, an entry of new class of carbonic anhydrase II inhibitors and evaluation of chemo-informatics and binding analysis","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2019.01.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}